We describe the case of late recurrence of a focus of invasive mucinous adenocarcinoma (formerly mucinous bronchioloalveolar carcinoma) following radiofrequency ablation, despite a negative positron emission tomography/computed tomography scan at 13 months following the ablation. A computed tomography scan performed at 24 months demonstrated unequivocal recurrence of the lesion. Combined positron emission tomography/computed tomography has been described as an adequate modality for the follow-up of thermally ablated pulmonary lesions. However, its utility in the follow-up of well-differentiated pulmonary adenocarcinoma may be limited. Lesion activity may be underestimated by an inherently low metabolic activity. Small lesions may also be susceptible to partial volume effect. Long-term imaging follow-up of well-differentiated pulmonary adenocarcinoma beyond two years after thermal ablation is prudent to avoid missing late recurrence.
CASE REPORT
In September 2008, a 50-year-old woman was referred to our department for computed tomography (CT) guided radiofrequency ablation (RFA) of a left upper lobe focus of invasive mucinous adenocarcinoma. The patient had been receiving treatment for multifocal pulmonary adenocarcinoma for 6 years prior to referral; this included right upper lobectomy in 2002, left lower lobectomy in 2004, and radiation therapy for recurrence of the right sided lesion in 2007. The present lesion of interest was located inferiorly in the left upper lobe, and measured 15.9 mm in longest axial diameter (Figure 1 ). Apart from changes consistent with the patient's previous treatments, the CT was otherwise unremarkable. Positron emission tomography (PET) was not performed as part of workup of this new lesion, due to the patient's extensive history of multifocal disease.
The patient elected to undergo thermal ablation of the lesion, rather than surgery, due to concerns of surgical morbidity related to previous surgical and radiotherapeutical procedures. Under sterile conditions and CT guidance, a 15cm (2cm active tip) Cooltip Radiofrequency Ablation Device (Covidien, Boulder, Colorado, USA) was initially inserted eccentrically through the lesion, which was in proximity to larger pulmonary vessels (Figure 2 ). Three overlapping ablations were performed, totalling 25 minutes ablation time. The intra-procedural alveolar haemorrhage remained clinically silent.
Follow-up CT scans of the chest was performed at 3 months ( Figure 3 ) and 6 months (Figure 4 ) following the ablation, demonstrating initial cavitation and subsequent progressive resolution of the ablated left upper lobe lesion, with residual scar formation. No other suspicious lesions were identified on these scans. 18F-fludeoxyglucose positron emission tomography/computed tomography (FDG-PET/CT) was not utilised in ablation follow-up, as it was not part of the protocol within our institution. demonstrate any CT evidence of recurrence ( Figure 5 ). However, on this scan a new right-sided retrocardiac intrapulmonary paramediastinal lesion was identified, located posterior to the right atrium at the level of T8, measuring 25.8 x 20.8 x 12.6 mm ( Figure 6 ). As part of tumor staging, an FDG-PET/CT scan was performed, at 13 months post ablation of the left-sided lesion. Negligible FDG uptake was registered at the previous left upper lobe ablation site; this was considered benign (Figure 7) . The new right-sided lung lesion demonstrated minor FDG-uptake (Figure 8 ). There was no other evidence of local or distant metastatic disease.
The patient received radiotherapy for the new right-sided lung tumor, with subsequent follow-up CT scans performed at 6-monthly intervals. One such monitoring CT scan, performed 24 months following initial referral, demonstrated unequivocal recurrence of the previously ablated left-sided lesion, measuring 19.9 x 17.4 x 14.9 mm (Figure 9 ).
Etiology and Demographics
Bronchioloalveolar carcinoma (BAC) represents a spectrum of disease ranging from noninvasive, to multifocal advanced disease [1] . The disease encompassed by the term BAC includes several subgroups of differing clinical and histopathological significance [1] . In response to this, a 2011 study sponsored by the International Association for the Study of Lung Cancer, the American Thoracic Society, and the European Respiratory Society (IASLC/ATS/ERS), published a new classification of adenocarcinoma of the lung [2] . Within this classification, the entity previously known as bronchioloalveolar carcinoma (BAC) has been divided into five distinct entities [2]: 1) adenocarcinoma in situ (AIS); 2) minimally invasive adenocarcinoma (MIA); 3) lepidic predominant adenocarcinoma, nonmucinous; 4) acinar, papillary, micropapillary or solid predominant adenocarcinoma, plus a lepidic component; 5) invasive mucinous adenocarcinoma. The committee has acknowledged that this new terminology will be a major adjustment for radiologists; thus, it has been suggested that the disease spectrum be referred to as "formerly BAC" [1] .
Formerly BAC demonstrate lepidic and/or aerogenous growth on histology [3] . The disease constitutes between 2 to 5% of all primary lung cancers [3] . Most epidemiological studies support a higher prevalence in women than in men [4] [5] [6] . Onset is typically at a younger age than other types of nonsmall-cell lung carcinoma (NSCLC) [7] .
Several studies have suggested that the proportion of nonsmoking patients with formerly BAC is higher than in other types of lung carcinoma [6] [7] [8] . Patients with nonmucinous formerly BAC are more likely to be nonsmokers [9] . Other proposed risk factors for formerly BAC include viral infection and pulmonary scarring [7] .
Clinical and Imaging Findings
The most common finding of formerly BAC on plain radiograph is a solitary peripheral nodule or mass of solid consistency [6] . 30% of all BAC are multifocal [6] .
Early focal formerly BAC may have three appearances on CT: 1) pure ground glass opacification (GGO), appearing as hazy increase in attenuation without obscuration of bronchovascular markings; 2) solid, with complete obscuration of bronchovascular markings; 3) mixed, with both of the above components [10] . Features of serial CT examination that may be suggestive of malignancy include increased size of GGO, evolution of a solid region in an area of GGO, or increased size of the solid component in a mixed lesion [10] . Advanced disease may be unifocal or multifocal, with pseudocavitations and air-bronchograms [10] . The CT angiogram sign may be present in contrast-enhanced CT, where enhancing vessels have higher attenuation than the surrounding mucinous lesion [10] .
FDG-PET may provide an advantage over CT in the investigation of malignant pulmonary disease through its ability to demonstrate the metabolic activity of tissues. However, there may be a high false-negative rate in the detection of BAC with FDG-PET, due to the slow proliferation and well-differentiated nature of the disease [7, 11] . A recent small series of seven patients with BAC found negative FDG-PET scans in four (57%) of the patients [11] . It has been suggested that positive scans are more likely to occur in patients with multifocal BAC [10] . The literature relating to ablation therapy of bronchioloalveolar carcinoma is in its early stages, and as such, there is no consensus relating to preablation FDG-PET/CT.
Treatment and prognosis
The gold standard management for solitary BAC is surgical excision [3, 7] . Thermal ablation therapies, including microwave and radiofrequency ablation, have become increasingly utilised in those patients who are ineligible for resection.
Ablation therapies aim to destroy the target malignant cells whilst minimising damage to surrounding normal parenchyma [12] . Since histopathological assessment of ablated tumour margins is not possible, close follow-up of patients undergoing lung tumour ablation is essential. However, there is no consensus in the literature regarding the appropriate modality, frequency or length of follow-up.
The prognosis of formerly BAC is considered better than that of other types of NSCLC, with micropapillary subtype having the worst prognosis; however, estimates are varied [3] . Prior to the new classification, formerly BAC was estimated to have overall survival rates of 72.5% at one year, and 41% at five years, with a mortality rate of 80% [3].
Our case describes the recurrence of a focus of formerly BAC following CT-guided radiofrequency ablation (RFA), despite a negative FDG-PET/CT scan at 13 months post ablation. The use of CT in the follow-up of pulmonary malignancies following ablative therapies is limited by the DISCUSSION difficulty in distinguishing treatment-related change from tumor recurrence/incomplete ablation [13] . Combined FDG-PET/CT has been recommended by a small number of authors for follow-up of ablated lung tumours [13, 14] . As previously described, FDG-PET of formerly BAC is fraught by a high rate of false-negatives [7, 11] . Well-differentiated pulmonary adenocarcinomas in particular exhibit mild degrees of atypia, desmoplasia and mitosis on histologic examination, which may lead to lower peak standardised uptake values (SUVs) when compared to other types of lung tumors [15] . In the short-term following lesion ablation, this problem is compounded, as inflammation and tissue regeneration can result in increased tracer uptake at the ablated site [16] . Most authors recommend that FDG-PET not be performed until at least 3 months postablation, to reduce the risk of false-positive results [13, 14] .
The standardised uptake value (SUV) on PET scans has been used to evaluate local tumour progression following ablation of pulmonary tumours. In 2003, Herrera et al described a modification of the Response Evaluation Criteria in Solid Tumours (RECIST) to assess treatment response following lung tumour ablation, with one of their criteria for complete response being an SUV of <2.5 on FDG-PET [17] . However, SUV may not be the most reliable predictor of ablation therapy success. Not only is there a risk of falsenegatives in the identification of formerly BAC, SUV may be unreliable in small lung lesions, as partial volume effects may lead to an underestimation of glucose uptake [15] .
Differential Diagnosis
Differential diagnoses for formerly BAC include: pulmonary metastases, pneumonia, pulmonary hamartoma and granuloma [18] [19] [20] . These lesions may be difficult to differentiate on plain chest radiography. CT provides more detailed information to distinguish between potential diagnoses. As described, the CT appearance of BAC may appear as a poorly defined hazy area of increased attenuation, with or without a solid component and areas of pseudocavitation [10] . Pulmonary metastases are typically enhancing nodules of varied margins, with associated lymphadenopathy [18] . Pulmonary pneumonia is often associated with atelectasis [19] . A pulmonary hamartoma is often more sharply marginated, with areas of calcification and fat [18, 20] . Similarly, a granuloma may have associated areas of calcification, with associated hilar lymph node calcification [18, 20] .
Conclusion
The literature to date has failed to address the issue of false-negatives in follow-up FDG-PET/CT scans after pulmonary thermal lesion ablation. To our knowledge, ours is the first described case of a false-negative FDG-PET/CT scan beyond one year following ablation. Ablation therapy of pulmonary malignancies remains an emerging field. It is clear that further research is needed into the ideal modality, and length of follow-up of thermally ablated pulmonary lesions.
The utility of FDG-PET/CT scans for well-differentiated pulmonary adenocarcinoma may be limited by the lesions' low metabolic activity, and the susceptibility of small lesions to partial volume effect. Long-term imaging follow-up beyond two years after thermal ablation is considered prudent to avoid missing late local recurrence and allows for potential retreatment. Peripheral nodule of increased density, characteristically peripheral and solitary [6] Poorly marginated nodule, characterized by focal areas of low attenuation (pseudocavitation) [18] ; vessels may appear prominent (CT angiogram sign) [ Increased density overlying a rib [18] Intraosseous increased density within rib [18] Cutaneous nodule Well-marginated areas of increased opacity projected over lung fields [18] Increased density within cutaneous soft tissues [18] Pneumonia Poorly marginated nodule, variable location We thank Aravind Ravi Kumar for providing the nuclear medicine images and invaluable expertise around the debatable topic of SUV, along with assistance with PET-related literature review.
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